期刊
CELL DEATH AND DIFFERENTIATION
卷 19, 期 10, 页码 1698-1708出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2012.52
关键词
atrophy; autophagy; glycogen storage disease; Pompe disease; MuRF1
资金
- AFM [14199, 15504]
- Telethon-Italy [GTB07001-DR, TCP04009]
- Eurobiobank network [QLRT2001-027769]
- ERC (MyoPHAGY) [282310]
Regulated removal of proteins and organelles by autophagy-lysosome system is critical for muscle homeostasis. Excessive activation of autophagy-dependent degradation contributes to muscle atrophy and cachexia. Conversely, inhibition of autophagy causes accumulation of protein aggregates and abnormal organelles, leading to myofiber degeneration and myopathy. Defects in lysosomal function result in severe muscle disorders such as Pompe (glycogen storage disease type II (GSDII)) disease, characterized by an accumulation of autophagosomes. However, whether autophagy is detrimental or not in muscle function of Pompe patients is unclear. We studied infantile and late-onset GSDII patients and correlated impairment of autophagy with muscle wasting. We also monitored autophagy in patients who received recombinant alpha-glucosidase. Our data show that infantile and late-onset patients have different levels of autophagic flux, accumulation of p62-positive protein aggregates and expression of atrophy-related genes. Although the infantile patients show impaired autophagic function, the late-onset patients display an interesting correlation among autophagy impairment, atrophy and disease progression. Moreover, reactivation of autophagy in vitro contributes to acid alpha-glucosidase maturation in both healthy and diseased myotubes. Together, our data suggest that autophagy protects myofibers from disease progression and atrophy in late-onset patients. Cell Death and Differentiation (2012) 19, 1698-1708; doi:10.1038/cdd.2012.52; published online 18 May 2012
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据